These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of laser-assisted delivery vs intralesional injection of botulinum toxin A in treatment of hypertrophic scars and keloids. Sabry HH; Ibrahim EA; Hamed AM Dermatol Ther; 2020 Nov; 33(6):e13980. PubMed ID: 32638463 [TBL] [Abstract][Full Text] [Related]
3. Effects of Botulinum Toxin on Improving Facial Surgical Scars: A Prospective, Split-Scar, Double-Blind, Randomized Controlled Trial. Hu L; Zou Y; Chang SJ; Qiu Y; Chen H; Gang M; Jin Y; Lin X Plast Reconstr Surg; 2018 Mar; 141(3):646-650. PubMed ID: 29481395 [TBL] [Abstract][Full Text] [Related]
4. Assessment of intralesional injection of botulinum toxin type A in hypertrophic scars and keloids: Clinical and pathological study. Khatery BHM; Hussein HA; Abd-El-Raheem TA; El Hanbuli HM; Yassen NN Dermatol Ther; 2022 Oct; 35(10):e15748. PubMed ID: 36190006 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of botulinum toxin type A for treating post burn hypertrophic scars and keloid in children: An intra-patient randomized controlled study. Tawfik AA; Ali RA J Cosmet Dermatol; 2023 Apr; 22(4):1256-1260. PubMed ID: 36718819 [TBL] [Abstract][Full Text] [Related]
6. A Randomized, Placebo-Controlled, Double-Blind, Prospective Clinical Trial of Botulinum Toxin Type A in Prevention of Hypertrophic Scar Development in Median Sternotomy Wound. Li YH; Yang J; Liu JQ; Xie ST; Zhang YJ; Zhang W; Zhang JL; Zheng Z; Hu DH Aesthetic Plast Surg; 2018 Oct; 42(5):1364-1369. PubMed ID: 30019241 [TBL] [Abstract][Full Text] [Related]
7. Intralesional triamcinolone alone or in combination with botulinium toxin A is ineffective for the treatment of formed keloid scar: A double blind controlled pilot study. Rasaii S; Sohrabian N; Gianfaldoni S; Hadibarhaghtalab M; Pazyar N; Bakhshaeekia A; Lotti T; Ramirez-Pacheco LA; Lange CS; Matta J; Seifi V; Ramirez-Fort MK; Feily A Dermatol Ther; 2019 Mar; 32(2):e12781. PubMed ID: 30422367 [TBL] [Abstract][Full Text] [Related]
8. The Efficacy and Safety of Early Postoperative Botulinum Toxin A Injection for Facial Scars. Lee SH; Min HJ; Kim YW; Cheon YW Aesthetic Plast Surg; 2018 Apr; 42(2):530-537. PubMed ID: 29214336 [TBL] [Abstract][Full Text] [Related]
9. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Saray Y; Güleç AT Int J Dermatol; 2005 Sep; 44(9):777-84. PubMed ID: 16135153 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A for the treatment of keloids. Gauglitz GG; Bureik D; Dombrowski Y; Pavicic T; Ruzicka T; Schauber J Skin Pharmacol Physiol; 2012; 25(6):313-8. PubMed ID: 22948093 [TBL] [Abstract][Full Text] [Related]
11. Effect of subcutaneous injection of botulinum toxin A on spinal cord injury-associated neuropathic pain. Han ZA; Song DH; Chung ME Spinal Cord; 2014 Jun; 52 Suppl 1():S5-6. PubMed ID: 24902645 [TBL] [Abstract][Full Text] [Related]
12. Effect of botulinum toxin type A for treating hypertrophic scars: A split-scar, double-blind randomized controlled trial. Elshahed AR; Elmanzalawy KS; Shehata H; ElSaie ML J Cosmet Dermatol; 2020 Sep; 19(9):2252-2258. PubMed ID: 32668499 [TBL] [Abstract][Full Text] [Related]
13. Early postoperative treatment of thyroidectomy scars using botulinum toxin: a split-scar, double-blind randomized controlled trial. Kim YS; Lee HJ; Cho SH; Lee JD; Kim HS Wound Repair Regen; 2014; 22(5):605-12. PubMed ID: 24898579 [TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury. Li G; Lv CA; Tian L; Jin LJ; Sun P; Zhao W Medicine (Baltimore); 2017 May; 96(20):e6919. PubMed ID: 28514309 [TBL] [Abstract][Full Text] [Related]
15. [Subcutaneous botulinum toxin in the treatment of peripheral neuropathic pain]. Puentes Gutiérrez AB; García Bascones M; Puentes Gutiérrez R; Díaz Jiménez M Rehabilitacion (Madr); 2019; 53(2):131-135. PubMed ID: 31186096 [TBL] [Abstract][Full Text] [Related]
16. The Efficacy and Safety of Botulinum Toxin Injections in Preventing Postoperative Scars and Improving Scar Quality: A Systematic Review and Meta-Analysis. Qiao Z; Yang H; Jin L; Li S; Wang X Aesthetic Plast Surg; 2021 Oct; 45(5):2350-2362. PubMed ID: 33674930 [TBL] [Abstract][Full Text] [Related]
17. A Systematic Review And Meta-Analysis: Botulinum Toxin A Effect on Postoperative Facial Scar Prevention. Yue S; Ju M; Su Z Aesthetic Plast Surg; 2022 Feb; 46(1):395-405. PubMed ID: 34609526 [TBL] [Abstract][Full Text] [Related]
18. Comparison of dual-plane micro-drop injection of botulinum toxin type A with two traditional methods for treating hypertrophic scars in the tension zone: A long-term clinical application study. Jiang B; Zhang J; Yang W; Wang Y; Huang S; Qiu J; Bian B; Zhang L; Zu W J Cosmet Dermatol; 2024 Oct; 23(10):3182-3188. PubMed ID: 38803042 [TBL] [Abstract][Full Text] [Related]
19. Assessment of intralesional injection of botulinum toxin type A injection for hypertrophic scars. Elhefnawy AM Indian J Dermatol Venereol Leprol; 2016; 82(3):279-83. PubMed ID: 27088929 [TBL] [Abstract][Full Text] [Related]
20. The Efficacy of Drug Injection in the Treatment of Pathological Scar: A Network Meta-analysis. Sun P; Lu X; Zhang H; Hu Z Aesthetic Plast Surg; 2021 Apr; 45(2):791-805. PubMed ID: 31853608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]